S

Sundararaman

Active Director Director DIN 02723579
DIN 02723579 First appointment Jul 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2005
Shareholding value •••• Premium profile

About Sundararaman

Data last updated:

Sundararaman is a Director at Medline Pharmaceuticals Private Limited (since 2005). The company operates in Pharma. Medline Pharmaceuticals Private Limited reported revenue of ₹1.33 Cr (FY 2024).

DIN 02723579
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2005
Oldest Company Age 21 yrs
Largest company Medline Pharmaceuticals Private Limited · ₹1.33 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20052005₹1.33 Cr (FY 2024)Active

Board colleagues of Sundararaman

Directorship timeline

Open interactive timeline →
Medline Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sundararaman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sundararaman

Sundararaman currently holds 1 directorship: Medline Pharmaceuticals Private Limited (Director, since 21 Jul 2005, revenue ₹1.33 Cr (FY 2024)).

Sundararaman was first appointed on 21 Jul 2005 as Director at Medline Pharmaceuticals Private Limited.

The current boards of Sundararaman's companies include Boominathan Nambi Narayana (Medline Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available